Chronic fondaparinux use in a hemodialysis patient with heparin‐induced thrombocytopenia type II and extracorporeal circuit thrombosis—A case report and review of the literature-Reference-Cited by-同舟云学术

Chronic fondaparinux use in a hemodialysis patient with heparin‐induced thrombocytopenia type II and extracorporeal circuit thrombosis—A case report and review of the literature

Published:2012-12-06 Issue:3 Volume:17 Page:444-449
ISSN:1492-7535
Container-title:Hemodialysis International
language:en
Short-container-title:Hemodial Int

Author:

Brown Paula¹,Jay Richard²,Fox Andrea¹,Oliver Matthew³

Affiliation:

1. Department of PharmacySunnybrook Health Sciences Centre Toronto Ontario Canada

2. Department of Medicine—HematologySunnybrook Health Sciences Centre Toronto Ontario Canada

3. Department of Medicine—NephrologySunnybrook Health Sciences Centre Toronto Ontario Canada

Publisher

Wiley

Subject

Nephrology,Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hdi.12003

Reference18 articles.

1. Antibodies to Heparin–Platelet Factor 4 Complex: Pathogenesis, Epidemiology, and Management of Heparin-Induced Thrombocytopenia in Hemodialysis

2. Essentials of anticoagulation in hemodialysis

3. Heparin-induced thrombocytopenia during renal replacement therapy

4. Fondaparinux for Thromboembolic Treatment and Prophylaxis of Heparin-Induced Thrombocytopenia

5. Heparin-induced thrombocytopenia: a renal perspective

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Population pharmacokinetics-pharmacodynamics of fondaparinux in dialysis-dependent chronic kidney disease patients undergoing chronic renal replacement therapy;European Journal of Clinical Pharmacology;2021-08-19

2. Management of heparin-induced thrombocytopenia: systematic reviews and meta-analyses;Blood Advances;2020-10-23

3. American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia;Blood Advances;2018-11-27

4. Antithrombotic medications in dialysis patients: a double-edged sword;Journal of Evidence-Based Medicine;2017-02

5. Fondaparinux: another potential treatment for heparin-induced thrombocytopenia type II?;Critical Care;2015-12